We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

215 hedge funds and large institutions have $2.47B invested in Arena Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

31% more capital invested

Capital invested by funds: $1.88B → $2.47B (+$586M)

19% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $16.4M

17% more funds holding

Funds holding: 184 → 215 (+31)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
215
Holders Change
+31
Holders Change %
+16.85%
% of All Funds
4.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
69
Reduced
43
Closed
23
Calls
$19.5M
Puts
$16.4M
Net Calls
+$3.06M
Net Calls Change
-$6.54M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
2
N
Nuveen
North Carolina
+$23.4M
3
EMG
ETF Managers Group
New Jersey
+$20.9M
4
Invesco
Invesco
Georgia
+$11.2M
5
MCM
Matarin Capital Management
New York
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$73.7M
2
RCMNY
Rubric Capital Management (New York)
New York
-$38.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$16.7M
4
MWNA
Marshall Wace North America
New York
-$16.5M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
226
Quantamental Technologies
New York
– -$63K -1,404 Closed
EP
227
Elkfork Partners
Oregon
– -$18K -408 Closed
GHCM
228
Glen Harbor Capital Management
California
– -$15K -336 Closed
MCIM
229
Meadow Creek Investment Management
Georgia
– -$12K -264 Closed
SWM
230
SeaCrest Wealth Management
New York
– -$9K -200 Closed
FCM
231
Flinton Capital Management
Pennsylvania
– -$9K -192 Closed
PNC Financial Services Group
232
PNC Financial Services Group
Pennsylvania
– -$3K -79 Closed
CHP
233
Cable Hill Partners
Oregon
– -$3K -73 Closed
MNBTD
234
Moody National Bank Trust Division
Texas
– -$3K -64 Closed
IRC
235
Investors Research Corp
Georgia
– -$2K -50 Closed
TRCT
236
Tower Research Capital (TRC)
New York
– -$1K -32 Closed
SHIM
237
Stone House Investment Management
Pennsylvania
– -$1K -18 Closed
HNB
238
Huntington National Bank
Ohio
– +$52 +1 New
6 7 8 9
10

ARNA Hedge Fund Activity: Q2 2019 in Review

215 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2019, worth a combined $2.47B — up 31% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ARNA positions and 23 closed out — a net gain of 35 holders — while 69 added to existing stakes and 43 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $50.6M. The largest seller was PFM Health Sciences, cutting an estimated $73.7M.

  • 215 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2019, up from 184 in Q1 2019.
  • Funds reported $2.47B of Arena Pharmaceuticals Inc stock for Q2 2019, up 31% quarter-over-quarter.
  • 58 funds opened new Arena Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of +35 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2019 was AllianceBernstein, an estimated $50.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2019 was PFM Health Sciences, an estimated $73.7M sold.

Based on aggregated 13F filings for Q2 2019.